Financial Gravity Asset Management, Inc. Dexcom Inc Transaction History

Financial Gravity Asset Management, Inc.

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 26, 2024	SELL	$114.22 - $140.1 $114 - $140	-1 Reduced 10.0%	9 $1.27 Million
Q1 2024 May 13, 2024	BUY	$114.22 - $140.1 $1,599 - $1,961	14 Added 140.0%	24 $3.49 Million
Q4 2023 Jun 26, 2024	SELL	$75.49 - $124.16 $1,056 - $1,738	-14 Reduced 58.33%	10 $1.26 Million
Q3 2023 Nov 15, 2023	SELL	$86.06 - $137.93 $10,241 - $16,413	-119 Reduced 92.25%	10 $0
Q2 2023 Aug 08, 2023	BUY	$112.47 - $130.98 $14,508 - $16,896	129 New	129 $1.03 Million
Q4 2022 Feb 15, 2023	BUY	$84.98 - $122.67 $9,602 - $13,861	113 New	113 $105,000
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $1.11 Million - $1.54 Million	-11,814 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$129.87 - $162.82 $1.53 Million - $1.92 Million	11,814 New	11,814 $2.68 Million
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $0 - $0	0 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $0 - $0	0 New	0 $0
Q2 2020 Aug 13, 2020	SELL	$62.68 - $105.34 $62 - $105	-1 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$47.79 - $75.63 $238 - $378	-5 Reduced 83.33%	1 $0
Q4 2019 Feb 28, 2020	SELL	$36.62 - $57.29 $36 - $57	-1 Reduced 14.29%	6 $219,000
Q2 2019 Jul 26, 2019	SELL	$27.84 - $38.92 $222 - $311	-8 Reduced 53.33%	7 $1,000
Q1 2019 Apr 19, 2019	SELL	$28.07 - $38.18 $1,515 - $2,061	-54 Reduced 78.26%	15 $2,000
Q3 2018 Oct 31, 2018	BUY	$23.35 - $36.72 $186 - $293	8 Added 13.11%	69 $9,000
Q2 2018 Aug 14, 2018	SELL	$17.54 - $25.22 $473 - $680	-27 Reduced 30.68%	61 $8,000
Q1 2018 May 23, 2018	BUY	$13.06 - $18.54 $1,149 - $1,631	88 New	88 $7,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $28.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.